CGEN vs ACHV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 28, 2026

CGEN

65.1
AI Score
VS
CGEN Wins

ACHV

64.6
AI Score

Investment Advisor Scores

CGEN

65score
Recommendation
BUY

ACHV

65score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CGEN ACHV Winner
Net Income 35.34M -16.39M CGEN
ROE 34.4% -90.8% CGEN
ROA 22.6% -77.8% CGEN
Total Assets 156.57M 21.08M CGEN
Cash 90.60M 16.66M CGEN
Current Ratio 6.56 6.04 CGEN
Free Cash Flow 31.33M -15.27M CGEN

Relative Price Performance (Last 90 Days)

CGEN 1M: -15.5% · 3M: -12.1% ACHV 1M: -10.6% · 3M: +12.2%

Current Technical Phase

CGEN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.3%), weak momentum, RSI 40

RSI (14): 39.6 · Price: $1.97

ACHV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.9 · Price: $6.93

Fundamentals Snapshot

Metric CGEN ACHV
Market Cap — —
Forward P/E -5.4 -10.6
Trailing P/E 4.9 —
Revenue (TTM) — —
Revenue Growth 1.1% 0.0%
Gross Margin 0.9% —
Operating Margin -3.4% 0.0%
EPS 0.38 -1.69
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CGEN is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.